Physician profile
John William Moore
NPI 1548462385
$18,733.60
in general payments reported to CMS, 2019-2025
23 companies · $2,886 in 2025
The $2,886 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,634 · 2020: $1,356 · 2021: $1,559 · 2022: $3,050 · 2023: $3,982 · 2024: $1,266 · 2025: $2,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,756 · Travel and Lodging: $2,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,756.33 |
| Travel and Lodging | $2,378.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $4,899.53 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Biosense Webster, INC. | $4,447.75 | 2019-2025 | Carto 3, Qdot Micro Catheter, Na |
| Boston Scientific Corporation | $2,758.82 | 2019-2025 | Watchman Access System, Watchman Flx, Rhythmia Mapping System |
| Abbott Laboratories | $2,213.52 | 2019-2025 | Aveir, Assurity, Jot Dx |
| Medtronic, INC. | $1,338.09 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Reveal Linq |
| Medical Device Business Services, INC. | $1,292.65 | 2023 | Carto 3 |
| Cardiva Medical, INC. | $495.69 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $263.25 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $209.94 | 2020-2024 | Camzyos, Eliquis |
| Philips North America LLC | $131.30 | 2022-2025 | (Ck4) Mcot, Extended Holter |
| Novartis Pharmaceuticals Corporation | $116.41 | 2020-2024 | |
| Impulse Dynamics (USA) INC. | $115.87 | 2023 | Optimizer |
| Medtronic Vascular, INC. | $93.67 | 2019-2020 | |
| Amgen INC. | $80.18 | 2021-2024 | Repatha |
| Medtronic USA, INC. | $54.02 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $46.65 | 2021-2023 | Xarelto |
| Edwards Lifesciences Corporation | $46.42 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $26.72 | 2021-2022 | |
| Allergan, INC. | $23.77 | 2020 | |
| Terumo Medical Corporation | $23.59 | 2022 | |
| Amryt Pharma Holdings LTD | $22.13 | 2021 | |
| Tactile Systems Technology INC | $19.39 | 2021 | |
| Pfizer INC. | $14.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.